The Future of Neonatal Cerebral Oxygenation Monitoring: Directions After the SafeBoosC-III Trial
J Pediatr
.
2024 Mar 15:270:114016.
doi: 10.1016/j.jpeds.2024.114016.
Online ahead of print.
Authors
Valerie Y Chock
1
,
Zachary A Vesoulis
2
,
Mohamed El-Dib
3
,
Topun Austin
4
,
Frank van Bel
5
Affiliations
1
Division of Neonatal and Developmental Medicine, Stanford University School of Medicine, Stanford, CA. Electronic address: vchock@stanford.edu.
2
Division of Newborn Medicine, Washington University, St. Louis, MO.
3
Division of Newborn Medicine, Department of Pediatrics, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
4
Neonatal Intensive Care Unit, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom.
5
Department of Neonatology, University Medical Center Utrecht, Utrecht, The Netherlands.
PMID:
38492916
DOI:
10.1016/j.jpeds.2024.114016
No abstract available
Keywords:
brain; near-infrared spectroscopy; neuromonitoring; preterm.